Updated 12:17 GMT, 21 Nov 2026 SPX 6,910.39 -3.70% NDX 25,028.98 -5.61% VIX 35.89 +26.20% GOLD 3,515.40 -4.62% CL 83.98 +0.93% BTC 58,232.43 -0.96%
NAS100 25,029 −5.61% S&P 6,910 −3.70% GOLD $3,515 −4.62% BTC $58,232 −0.96% VIX 35.89 +26.20% latest tape · as of 12:17 UTC
The Screen · Healthcare · Biotechnology

MeiraGTx Holdings plc

MGTX · Nasdaq · USD · Market cap $864M · 400 employees

MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases.

PASS · Titan Ethical · score 93.7
7.98 USD

Price as of 20 Nov 2026Daily close, not a live quote

Screened 2026-11-20 · the tape above runs as of 12:17 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price7.98 USD at the 20 Nov 2026 close
  • Fair valueUnder review: our model's value is 2.94x the price, above our 2.00x limit.
  • Our regime readDistribution, as of 17 Nov 2026
  • Ethical screenPasses, score 93.7 out of 100
  • OptionsOpen interest leans to puts (put/call 1.00)
  • Last reviewed20 Nov 2026 (1 day ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: range not available (screen dated 2026-11-20).

Current read
Distribution ?
Screened · screened 2026-11-20
  • Trend Distribution
  • Insiders insiders sold, $294,292, latest filing 2026-10-06
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 1.00, read 2026-11-20
  • Ethical passes the values gate
Price7.98 USD
Fair valueUnder review
Ethical score93.7/100
Our investment reviews on this name
2026-11-07Read Distribution9.00-11.3% to today ✓Markdown gives way to Distribution after a 19% slide in 5 weeks
2026-10-02Read Markdown11.05-27.8% to today ✓Accumulation gives way to Markdown after a 26% slide in 4 weeks
2026-09-05Read Accumulation14.97-46.7% to today Markup gives way to Accumulation after a 22% rise in 4 weeks
2026-08-05Read Markup12.29-35.1% to today Accumulation gives way to Markup after a 37% rise in 5 weeks

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

MeiraGTx Holdings plc holds its Distribution at $7.98. The statistical read favours the sellers, held for 11 days.

As held on the ledger · 2026-11-20
PhaseDistribution · caution
Quantitative stateThe statistical read favours the sellers, held for 11 days
Price at the screen$7.98
Valuation10.34 trailing · -5.90 forward price to earnings
Values screenPASS · score 93.7
Beta1.07
The Workings

Five Screens: MGTX's Results

PASS. All five recorded results clear their limits.

TestFigureLimitStatus
Business activity Permissible Permissible core business Pass
Debt load 9.61% Below 33% Pass
Interest-bearing cash 7.14% Below 33% Pass
Receivables 0.00% Below 49% Pass
Revenue purity 2.23% Below 5% Pass

Definitions, sources and threshold rules: ticker values-screen methodology.

The Ethical Read

Why It Clears, in Plain English

PASS · Titan Ethical

MeiraGTx clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 10%, inside the ~33% line, and interest is about 2% of its income, under the ~5% line, so it passes.

Read as at 20 Nov 2026. It updates when the underlying figures move, and past reads are kept below. How we screen.

Follow this verdict

Get an email when MGTX's ethical verdict changes

Today MGTX passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Fair value under review. Our model's value is 2.94x the price, above our 2.00x limit. We show no fair value, margin of safety or value read built on it until the review clears.

Method.

The Street's Range
16.00Street low 23.50Street average 50.00Street high 7.98Price

Street. Average target +194%.

Chart
The Business, in Plain Words
The fundamentals · plain-English read
Forward P/E-5.9x
Trailing P/E10.3xreasonably valued
EPS, trailing0.87
EPS, forward-1.53
Revenue growth+8,608.6%growing very fast
Profit margin19.9%healthy profit margins
Return on equity72.2%an exceptional return on shareholder capital
FCF yield6.53%
Debt to equity0.52moderate, manageable leverage
Current ratio3.76comfortably covers its short-term bills
Beta1.07moves a little more than the market
Short interest, float0.09%
52-week range6.62 - 15.35
Market cap$864M
Employees400

MGTX-specific watchpoints · The things to watch: it's a small-cap, so the share price can swing harder than the market; as a biotechnology name, trial and regulatory outcomes can move it sharply either way.

Metric definitions and interpretation rules: ticker-page methodology.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-20 Distribution $8.14 -2.2% Entry 20
2026-11-19 Distribution $8.32 -14.0% Entry 19
2026-11-12 Distribution $9.68 +0.6% Entry 18
2026-11-11 Distribution $9.62 +1.4% Entry 17
2026-11-10 Distribution $9.49 +5.4% Entry 16
2026-11-09 Distribution $9.00 +0.0% Entry 15
2026-11-08 Distribution $9.00 +0.0% Entry 14
2026-11-07 Distribution · changed $9.00 +5.8% Entry 13

The framework has shifted from markdown to distribution since the last review.

2026-11-06 Markdown $8.51 -9.7% Entry 12
2026-11-05 Markdown $9.42 -1.1% Entry 11

Earnings landed in this window. Ethical screening: PASS.

Written on its date, before the outcome; never pruned.

Latest News · What the Market Is Reading on MGTX

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in MGTX's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · MGTX
DateInsiderTitleTypeSharesValue
2026-10-06 Naylor Stuart CHIEF SCI OFCR, OPHTHALMOLOGY S - Sale 27,659 $294,292
2026-05-19 FORBES ALEXANDRIA Chief Executive Officer 62,000 $568,540
2026-04-21 GIROUX RICHARD Chief Operating Officer 56,000 $572,320
2026-04-17 PERCEPTIVE ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security 555,555 $4,999,995
2026-04-07 NAYLOR STUART Officer 27,661 $258,907
2026-03-24 FORBES ALEXANDRIA Chief Executive Officer 62,000 $459,420
2026-02-20 FORBES ALEXANDRIA Chief Executive Officer 62,500 ·
2026-02-20 ZELDIN ROBERT K Officer 7,500 ·
2026-02-20 GIROUX RICHARD Chief Operating Officer 60,000 ·
2026-02-20 NAYLOR STUART Officer 25,000 ·

Public filings, recorded as found. The full tape lives at Insider Intelligence.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $9.90 -8.7% · $913 -8.7%
2 months $8.97 +0.8% · $1,008 +0.8%
3 months $7.64 +18.3% · $1,183 +18.3%
6 months $8.72 +3.7% · $1,037 +3.7%
1 year $6.86 +31.8% · $1,318 +31.8%
2 years $4.80 +88.3% · $1,883 +88.3%
3 years $8.07 +12.0% · $1,120 +12.0%
5 years $14.90 -39.3% · $607 -39.3%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever MGTX does next, these words stay.

MeiraGTx Holdings plc · MGTX · Distribution · $7.98
Recorded 2026-11-20 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.